Pregunta del mes | Kern Pharma Biologics

Early mortality and overall survival of acute myeloid leukemia based on facility type

0
0 / 5 (0 votos)

American Journal of Hematology
First published
: 1 June 2017
DOI: 10.1002/ajh.24767

Vijaya R. Bhatt, Valerie Shostrom, Smith Giri, Krishna Gundabolu, K. M. Monirul Islam, Frederick R. Appelbaum, Lori J. Maness

Cancer health disparities may exist based on the facility type. We aimed to determine the association between the academic status of centers and outcomes of patients with acute myeloid leukemia (AML). Using the National Cancer Data Base, we compared 1-month mortality and long-term overall survival (OS) of 60 738 patients with AML, who received first course treatment between 2003 and 2011 at academic or nonacademic centers (community cancer program, comprehensive community cancer program, and others). Multivariate analysis was done using logistic regression for one-month mortality and Cox regression with backward elimination approach for OS. Patients treated at academic centers differed from those at nonacademic…

Seguir leyendo